Family Medicine · Knox, IN
NPI
1548277288
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
104 E Culver Rd Ste 102
Knox, IN, 46534
Phone (574) 772-7918
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,397
51 services
Medicare patients, 2024
40
Average age 74
Drug cost, 2024
$1.4M
29,277 prescriptions
Company payments, 2025
$1,117
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas M Browne was code 99213 (office e&m - established), 21 times for 21 patients. In total Thomas M Browne billed 51 services in 10 codes, and Medicare paid $1,397.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 21 | 21 | $45.16 | $948 |
| 81002 Clinical Chemistry | Office | 18 | 17 | $3.41 | $61.38 |
By year: 2022 $653 for 40 services; 2023 $5,476 for 155 services; 2024 $1,397 for 51 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 18 | 17 | $3.41 | $61.38 |
Medicare prescription drug claims, 2024
In 2024, the drug Thomas M Browne prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,985 prescriptions and refills. In total Thomas M Browne wrote 29,277 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,985 | 2,207 | 171 | $15K |
| Sertraline Hcl Generic | 1,448 | 1,505 | 79 | $8,273 |
| Pantoprazole Sodium Generic | 1,220 | 1,314 | 111 | $11K |
| Donepezil Hcl Generic | 1,117 | 1,133 | 48 | $7,427 |
| Furosemide Generic | 1,112 | 1,189 | 87 | $5,237 |
| Memantine Hcl Generic | 1,029 | 1,035 | 39 | $21K |
| Lisinopril Generic | 948 | 1,145 | 104 | $5,619 |
| Gabapentin Generic | 912 | 952 | 74 | $7,538 |
| Amlodipine Besylate Generic | 899 | 1,064 | 87 | $4,618 |
| Levothyroxine Sodium Generic | 832 | 1,028 | 94 | $6,473 |
| Eliquis Apixaban | 604 | 637 | 45 | $134K |
| Metoprolol Succinate Generic | 598 | 709 | 60 | $6,149 |
| Carvedilol Generic | 586 | 646 | 55 | $3,622 |
| Tamsulosin Hcl Generic | 579 | 661 | 58 | $5,850 |
| Potassium Chloride Generic | 571 | 623 | 60 | $12K |
Brand drugs: 2,418 claims; generic drugs: 26,823 claims; opioid claims: 845.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas M Browne $1,117 ($1,117 in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $203.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 5 | $203 |
| Vanda Pharmaceuticals Inc. VNDA | 6 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 8 | $155 |
| Abbvie Inc. ABBV | 10 | $154 |
| Lilly USA, LLC LLY | 5 | $101 |
| Novo Nordisk Inc NVO | 3 | $66.26 |
| Exact Sciences Corporation EXAS | 3 | $59.33 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $48.94 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $39.02 |
| Almatica Pharma LLC | 2 | $32.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.